THTX: Theratechnologies Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 68.97
Enterprise Value ($M) 94.98
Book Value ($M) -24.60
Book Value / Share -0.54
Price / Book -2.80
NCAV ($M) -38.75
NCAV / Share -0.84
Price / NCAV -1.78

Profitability (mra)
Return on Invested Capital (ROIC) -0.52
Return on Assets (ROA) -0.23
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.03
Current Ratio 1.15

Balance Sheet (mrq) ($M)
Current Assets 57.94
Assets 72.09
Liabilities 96.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 81.76
Operating Income -8.66
Net Income -23.96

Cash Flow Statement (mra) ($M)
Cash From Operations -5.68
Cash from Investing 1.11
Cash from Financing 14.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Nantahala Capital Management, LLC 5.80
02-07 13G/A Hirschman Orin 8.10 -10.36
11-28 13D Soleus Capital Master Fund, L.P. 10.50
11-13 13D Investissement Quebec 19.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-12 1,103 19,114 5.77
2024-04-11 2,366 3,348 70.67
2024-04-10 11,862 3,655 324.54
2024-04-09 13,466 5,325 252.88
2024-04-08 6,109 1,817 336.21

(click for more detail)

Similar Companies
TFFP – TFF Pharmaceuticals, Inc. TGTX – TG Therapeutics, Inc.
THAR – Tharimmune, Inc. TIL – Instil Bio, Inc.
TLSA – Tiziana Life Sciences Ltd


Financial data and stock pages provided by
Fintel.io